Association of the

ACTN3 athlete candidate genes single nucleotide variant skeletal muscles sports genetics

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
25 07 2023
Historique:
received: 28 06 2023
revised: 15 07 2023
accepted: 24 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

An elite athlete's status is associated with a multifactorial phenotype depending on many environmental and genetic factors. Of course, the peculiarities of the structure and function of skeletal muscles are among the most important characteristics in the context of athletic performance. To study the associations of SNV rs1815739 (C577T or R577X) allelic variants and genotypes of the A total of 126 people of European origin who lived in the Southern Urals region took part in this study. The first group included 76 cyclical sports athletes (speed skating, running disciplines in track-and-field): SD (short distances) subgroup-40 sprinters (mean 22.1 ± 2.4 y.o.); LD (long distances) subgroup-36 stayer athletes (mean 22.6 ± 2.7 y.o.). The control group consisted of 50 healthy nonathletes (mean 21.4 ± 2.7 y.o.). We used the Step One Real-Time PCR System (Applied Biosystems, USA) device for real-time polymerase chain reaction. The frequency of the major allele R was significantly higher in the SD subgroup compared to the control subgroup (80% vs. 64%; Multiplicative and additive inheritance models demonstrated that high athletic performance for sprinters was associated with the homozygous dominant genotype 577RR in cyclical sports athletes of Caucasian origin in the Southern Urals.

Identifiants

pubmed: 37628564
pii: genes14081512
doi: 10.3390/genes14081512
pmc: PMC10454296
pii:
doi:

Substances chimiques

Nucleotides 0
ACTN3 protein, human 0
Actinin 11003-00-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2020 Nov 5;10(1):19129
pubmed: 33154439
J Physiol. 2003 Feb 1;546(Pt 3):851-8
pubmed: 12563009
BMC Genomics. 2016 Apr 13;17:285
pubmed: 27075997
Biol Sport. 2014 Jun;31(2):105-8
pubmed: 24899773
Eur J Appl Physiol. 2019 Jan;119(1):49-60
pubmed: 30327870
Cell Metab. 2013 Feb 5;17(2):162-84
pubmed: 23395166
Sports (Basel). 2020 Jul 13;8(7):
pubmed: 32668587
J Med Microbiol. 2006 Sep;55(Pt 9):1187-1191
pubmed: 16914647
Med Sci Sports Exerc. 2016 Mar;48(3):509-20
pubmed: 26429734
Int J Sports Physiol Perform. 2015 Jul;10(5):636-41
pubmed: 25569611
J Hum Kinet. 2019 Aug 21;68:17-36
pubmed: 31531130
Med Sci Sports Exerc. 2010 Jan;42(1):107-12
pubmed: 20010124
Med Sport Sci. 2016;61:41-54
pubmed: 27287076
Exp Physiol. 2011 Dec;96(12):1302-10
pubmed: 21930675
Sports (Basel). 2018 Aug 30;6(3):
pubmed: 30200182
Hum Mutat. 2011 Sep;32(9):1008-18
pubmed: 21542061
Biochim Biophys Acta. 2016 Apr;1863(4):686-93
pubmed: 26802899
Hum Mutat. 2018 Dec;39(12):1774-1787
pubmed: 30281865
PLoS One. 2015 Feb 23;10(2):e0115449
pubmed: 25706920

Auteurs

Olga V Balberova (OV)

Research Institute of Olympic Sports, Ural State University of Physical Culture, 454091 Chelyabinsk, Russia.

Natalia A Shnayder (NA)

Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, 192019 St. Petersburg, Russia.
Shared Core Facilities Molecular and Cell Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.

Evgeny V Bykov (EV)

Research Institute of Olympic Sports, Ural State University of Physical Culture, 454091 Chelyabinsk, Russia.

Yuri E Zakaryukin (YE)

Research Institute of Olympic Sports, Ural State University of Physical Culture, 454091 Chelyabinsk, Russia.

Marina M Petrova (MM)

Shared Core Facilities Molecular and Cell Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.

Irina A Soloveva (IA)

Shared Core Facilities Molecular and Cell Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.

Ekaterina A Narodova (EA)

Shared Core Facilities Molecular and Cell Technologies, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.

Galina A Chumakova (GA)

Department of Therapy and General Medical Practice with a Course of Additional Professional Education, Altai State Medical University, 656038 Barnaul, Russia.

Mustafa Al-Zamil (M)

Department of Physiotherapy, Faculty of Continuing Medical Education, Peoples' Friendship University of Russia, 117198 Moscow, Russia.

Azat R Asadullin (AR)

Department of Psychiatry and Addiction, Bashkir State Medical University, 450008 Ufa, Russia.

Elena E Vaiman (EE)

Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, 192019 St. Petersburg, Russia.

Vera V Trefilova (VV)

Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, 192019 St. Petersburg, Russia.

Regina F Nasyrova (RF)

Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, 192019 St. Petersburg, Russia.
International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, 443016 Samara, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH